Based on Disposable Technologies
Innovative production of biological products opened at the State Complex R-Pharm in Yaroslavl.
The therapeutic protein production line is equipped with a unique intergrated platform FlexFactory GE Healthcare Life Sciences. The production, based on so-called “disposable technologies”, helps within a very short time develop significant volumes of hi-tech products, e.g. monoclonal antibodies, helping achieve significant saving on costs and time.
After use disposable elements are quickly recycled, replaced with new, providing flexibility of production processes, a possibility to change the line for manufacture of new products, as needed.
Thanks to a consistent automation system, the process of production may be controlled, and individual processes may be adjusted to facilitate installation, mounting and operation of equipment. Besides, “disposable technologies” help exclude the risk of contamination of products, and save the costs for purification of the technological line after each new launch of a batch of product.
The launch of a new line of biopharmaceutical drugs is an important step towards industrial production of biological products in Russia, including innovative products and biosimilars with high export potential.
According to Sergey Tsyb, Deputy Minister of Industry and Trade of the Russian Federation is a strong argument in favor of chosen references, goal setting. That is why the companies provide active assistance in achievement of values, that Russian pharma industry is facing, within the framework of implementation of Pharma-2020.